ROCHESTER, N.Y., Feb. 9, 2011 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N) ( www.naturalnano.com ), announced today the issuance of a US patent covering methods for optimizing the processes used to incorporate NaturalNano's Halloysite Natural Tubes (HNTs) in polymers. US Patent 7,888,914 covers the methods NaturalNano developed to optimize HNT performance over a wide array of plastic manufacturing processes.
Acting CEO James Wemett said, "The timing of the issued patent corresponds with our efforts to further strengthen our position in the growing engineered-polymer industry. We are very pleased with the breadth of claims that have been allowed."
Use of HNTs in traditional plastics manufacturing processes requires specialized treatment of the raw materials and use of surface-treatment chemistry to further improve physical properties. NaturalNano has developed a two-stage "master batch" process for the incorporation of HNTs that provides more uniform mixing and distribution. This in turn increases performance of components, adhesives, and other coatings manufactured under this process.
Mr. Wemett further commented, "We are working directly with major plastic component companies and are exploring the licensing of our technology to the up-stream polymer suppliers as well."
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.
CONTACT: Jim Wemett email@example.com NaturalNano, Inc. 585-267-4848